Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants
- 15 November 2002
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 100 (10), 3825-3827
- https://doi.org/10.1182/blood-2002-04-1197
Abstract
One of the functions of HLA class I alleles is interaction with natural killer (NK) cells. Receptors termed killer immunoglobulinlike receptors (KIRs) on NK cells recognize groups of HLA class I alleles, and interaction between receptor and class I allele inhibits reactivity of the NK cell. Failure to recognize the appropriate KIR ligand on a mismatched cell can trigger NK cell elimination of that target cell. Recent analysis of haploidentical hematopoietic transplantations has shown a reduction of graft failure, graft-versus-host disease, and relapse in those with KIR ligand incompatibility in the graft-versus-host direction. In this study we analyzed the effect of KIR ligand incompatibility on outcomes of unrelated donor bone marrow transplantations. The data show no advantage for KIR ligand incompatibility in this clinical setting as assessed by HLA-Bw4 and HLA-C alleles. It is possible that there will be a benefit of NK cell alloreactivity if strategies of haploidentical transplantation are used: high stem cell doses, extensive T-cell depletion, and no postgrafting immune suppression.Keywords
This publication has 11 references indexed in Scilit:
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human DonorsImmunity, 1997
- NON-PARAMETRIC INFERENCE FOR CUMULATIVE INCIDENCE FUNCTIONS IN COMPETING RISKS STUDIESStatistics in Medicine, 1997
- Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated miceNature Medicine, 1995
- Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trialBlood, 1990
- Prevention of Allogeneic Bone Marrow Graft Rejection by H-2 Transgene in Donor MiceScience, 1989
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958